Question

In: Accounting

Below is the trial balance of Rod Ropes Ltd, year ending 31st May 2020: DR CR...

Below is the trial balance of Rod Ropes Ltd, year ending 31st May 2020:

DR

CR

£

£

10% Debenture, 2030

100,000

Debenture Interest

8,000

Inventory (stock) at (01/06/19)

210,000

Administration expenses

23,000

Purchase returns

2,000

Marketing expenses

11,500

Bank

13,200

Sales

392,000

Purchases

252,000

Discounts Allowed

5,300

Discounts Received

3,000

Provision for Doubtful Debtors (at 01/06/19)

3,000

Non-current Assets at costs:

Motor Vehicles

50,000

Fixtures and Fittings

12,000

Freehold land

50,000

Accumulated Depreciation (at 01/06/19):

Motor Vehicles

10,000

Fixtures and Fittings

2,400

Trade Payables (Creditors)

46,900

Trade Receivables (Debtors)

140,000

Retained profits (at 01/06/19)

45,700

Share capital

170,000

775,000

775,000

Notes: The following have not yet been reflected in the trial balance.

i) Inventory (stock) at 31/05/20 was valued at £260,000.

ii) Within administration expenses there is a prepayment of £3,000 that needs to be reflected.

iii) As at the 31/05/20 there was Marketing expenses owing of £5,000 that needs an accrual.

iv) Provision for doubtful debtors is to be 5% of outstanding trade receivables (debtors) as at

31/05/20.

v) Depreciation: Motor Vehicles, Reducing Balance Method 20% Fixtures and Fittings, Straight

Line Method 10%

vi) Tax on profit after interest of £30,000 has not yet been paid.

vii) Debenture interest has partly been paid however the remaining needs to be accrued for.

Additional note: There were no dividends paid during the year (interim) or due to be paid at the

end of the year.

(a) Prepare the Statement of Profit or Loss for the year ending 31st May 2020.

(b) Prepare the Statement of Financial Position as at 31st May 2020.

(c) Define and illustrate one (1) accounting concept that you have used in constructing the financial

statements above.

(d) State and briefly explain one (1) characteristic of what makes ‘good’ accounting information.

Solutions

Expert Solution


Related Solutions

Big Bang Co provided you with the trial balance as at 31st Dec 20X3 Dr Cr...
Big Bang Co provided you with the trial balance as at 31st Dec 20X3 Dr Cr £000 £000 Land and Buildings at cost 5,000 Fixtures and Fittings at cost 1,980 Motor Vehicles at cost 200 Accum depn at 1/1/20X3 – Land 1,000 Accum depn at 1/1/20X3 – F&F 260 Accum depn at 1/1/20X3 – MV 80 Overdraft 55 Revenue 2,090 Purchases 360 Inventory 1/1/20X3 30 Trade payables 75 Trade receivables 120 Operating expenses 280 Allowance for receivables 5 Retained earnings...
Selected worksheet data for jane Freeman Company presented below: Trial Balance Adjusted Trial Balance Dr Cr...
Selected worksheet data for jane Freeman Company presented below: Trial Balance Adjusted Trial Balance Dr Cr Dr Cr Account Receivable ? 34000 Prepaid Insurance 26000 18000 Supplies 7000 ? Accumulated Depreciation 12000 ? Salaries payable ? 5000 Service Revenue 88000 95000 Insurance Expenses ? Depreciation Expenses 10000 Supplies Expenses 4000 Salaries Expenses ? 49000 Instructions: A)Fill in the missing amounts Trial Balance Adjusted Trial balance Dr Cr Dr Cr Account Receivable ? 34000 Prepaid Insurance 26000 18000 Supplies 7000 ?...
Question 22 A Belgium subsidiary's beginning and ending trial balances appear below: Dr (Cr) January 1...
Question 22 A Belgium subsidiary's beginning and ending trial balances appear below: Dr (Cr) January 1 December 31 Cash, receivables € 1,500 € 1,200 Inventories 3,000 3,500 Plant & equipment, net 30,000 39,000 Liabilities (18,500) (27,200) Capital stock (4,000) (4,000) Retained earnings, beginning (12,000) (12,000) Sales revenue -- (15,000) Cost of sales 9,500 Out-of-pocket selling & administrative expenses -- 4,000 Depreciation expense -- 1,000 Total € 0 € 0 Exchange rates ($/€) are: Beginning of year $1.25 Average for year...
A Belgium subsidiary's beginning and ending trial balances appear below: Dr (Cr) January 1 December 31...
A Belgium subsidiary's beginning and ending trial balances appear below: Dr (Cr) January 1 December 31 Cash, receivables € 1,500 € 1,200 Inventories 3,000 3,500 Plant & equipment, net 30,000 39,000 Liabilities (18,500) (27,200) Capital stock (4,000) (4,000) Retained earnings, beginning (12,000) (12,000) Sales revenue -- (15,000) Cost of sales 9,500 Out-of-pocket selling & administrative expenses -- 4,000 Depreciation expense -- 1,000 Total € 0 € 0 Exchange rates ($/€) are: Beginning of year $1.25 Average for year 1.22 End...
A Belgium subsidiary's beginning and ending trial balances appear below: Dr (Cr) January 1 December 31...
A Belgium subsidiary's beginning and ending trial balances appear below: Dr (Cr) January 1 December 31 Cash, receivables € 1,500 € 1,200 Inventories 3,000 3,500 Plant & equipment, net 30,000 39,000 Liabilities (18,500) (27,200) Capital stock (4,000) (4,000) Retained earnings, beginning (12,000) (12,000) Sales revenue -- (15,000) Cost of sales 9,500 Out-of-pocket selling & administrative expenses -- 4,000 Depreciation expense -- 1,000 Total € 0 € 0 Exchange rates ($/€) are: Beginning of year $1.25 Average for year 1.22 End...
A Belgium subsidiary's beginning and ending trial balances appear below: Dr (Cr) January 1 December 31...
A Belgium subsidiary's beginning and ending trial balances appear below: Dr (Cr) January 1 December 31 Cash, receivables € 1,500 € 1,200 Inventories 3,000 3,500 Plant & equipment, net 30,000 39,000 Liabilities (18,500) (27,200) Capital stock (4,000) (4,000) Retained earnings, beginning (12,000) (12,000) Sales revenue -- (15,000) Cost of sales 9,500 Out-of-pocket selling & administrative expenses -- 4,000 Depreciation expense -- 1,000 Total € 0 € 0 Exchange rates ($/€) are: Beginning of year $1.25 Average for year 1.22 End...
A Belgium subsidiary's beginning and ending trial balances appear below: Dr (Cr) January 1 December 31...
A Belgium subsidiary's beginning and ending trial balances appear below: Dr (Cr) January 1 December 31 Cash, receivables € 1,500 € 1,200 Inventories 3,000 3,500 Plant & equipment, net 30,000 39,000 Liabilities (18,500) (27,200) Capital stock (4,000) (4,000) Retained earnings, beginning (12,000) (12,000) Sales revenue -- (15,000) Cost of sales 9,500 Out-of-pocket selling & administrative expenses -- 4,000 Depreciation expense -- 1,000 Total € 0 € 0 Exchange rates ($/€) are: Beginning of year $1.25 Average for year 1.22 End...
Provide the closing entry for the following trial balance at year end: DR.                   CR. Cash          &n
Provide the closing entry for the following trial balance at year end: DR.                   CR. Cash                             $5,275 A/R                               $1,850 Equipment                   $56,480 A/P                                                       $12,350 Owners Capital                                     $70,405 Owners Withdrawals    $6,000 Revenue                                              $85,000 Cost of Goods Sold        $25,000 Salaries                        $50,000           Payroll Taxes                $8,900 Utilities                        $13,800
A partial trial balance of Indigo Corporation is as follows on December 31, 2021. Dr. Cr....
A partial trial balance of Indigo Corporation is as follows on December 31, 2021. Dr. Cr. Supplies $2,900 Salaries and wages payable $1,500 Interest Receivable 5,100 Prepaid Insurance 95,700 Unearned Rent 0 Interest Payable 15,400 Additional adjusting data: 1. A physical count of supplies on hand on December 31, 2021, totaled $1,200. 2. Through oversight, the Salaries and Wages Payable account was not changed during 2021. Accrued salaries and wages on December 31, 2021, amounted to $4,400. 3. The Interest...
A partial trial balance of Novak Corporation is as follows on December 31, 2021. Dr. Cr....
A partial trial balance of Novak Corporation is as follows on December 31, 2021. Dr. Cr. Supplies $2,600 Salaries and wages payable $1,300 Interest Receivable 5,000 Prepaid Insurance 89,600 Unearned Rent 0 Interest Payable 14,900 Additional adjusting data: 1. A physical count of supplies on hand on December 31, 2021, totaled $1,000. 2. Through oversight, the Salaries and Wages Payable account was not changed during 2021. Accrued salaries and wages on December 31, 2021, amounted to $4,700. 3. The Interest...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT